Traditional neurological assessments are slow, subjective, and difficult to do remotely. Winterlight’s technology can extract speech-based digital biomarkers from short snippets of speech. The Winterlight Assessment is currently used in multiple clinical trials to track changes and identify treatment responses. Our end-to-end solution supports life science partners from data collection through to results interpretation. In addition, our API allows for seamless integration with existing digital health platforms to continuously process speech and produce fast results.

Winterlight Labs Logo



Event details

Date: June 13 - 16, 2022

Event contact

Patricia Cosgrove
Area Director
USA: Life Sciences


26 in total